Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 280

1.

Outcomes and Long-Term Follow-Up with the Use of Ureteral Access Sheath for Pediatric Ureteroscopy and Stone Treatment: Results from a Tertiary Endourology Center.

Anbarasan R, Griffin SJ, Somani BK.

J Endourol. 2019 Jan 7. doi: 10.1089/end.2018.0448. [Epub ahead of print]

PMID:
30511885
2.

Descriptive epidemiology of changes in objectively measured sedentary behaviour and physical activity: six-year follow-up of the EPIC-Norfolk cohort.

Hajna S, White T, Brage S, van Sluijs EMF, Westgate K, Jones AP, Luben R, Khaw KT, Wareham NJ, Griffin SJ.

Int J Behav Nutr Phys Act. 2018 Nov 27;15(1):122. doi: 10.1186/s12966-018-0746-5.

3.

Validity of ultrasonography to assess hepatic steatosis compared to magnetic resonance spectroscopy as a criterion method in older adults.

De Lucia Rolfe E, Brage S, Sleigh A, Finucane F, Griffin SJ, Wareham NJ, Ong KK, Forouhi NG.

PLoS One. 2018 Nov 26;13(11):e0207923. doi: 10.1371/journal.pone.0207923. eCollection 2018.

4.

Genome-wide association study for risk taking propensity indicates shared pathways with body mass index.

Clifton EAD, Perry JRB, Imamura F, Lotta LA, Brage S, Forouhi NG, Griffin SJ, Wareham NJ, Ong KK, Day FR.

Commun Biol. 2018 May 3;1:36. doi: 10.1038/s42003-018-0042-6. eCollection 2018.

5.

Development and Validation of Lifestyle-Based Models to Predict Incidence of the Most Common Potentially Preventable Cancers.

Usher-Smith JA, Sharp SJ, Luben R, Griffin SJ.

Cancer Epidemiol Biomarkers Prev. 2019 Jan;28(1):67-75. doi: 10.1158/1055-9965.EPI-18-0400. Epub 2018 Sep 13.

PMID:
30213791
6.

Third-wave cognitive behaviour therapies for weight management: systematic review and network meta-analysis protocol.

Lawlor ER, Islam N, Griffin SJ, Hill AJ, Hughes CA, Ahern AL.

BMJ Open. 2018 Aug 1;8(7):e023425. doi: 10.1136/bmjopen-2018-023425.

7.

A randomised controlled trial of the effect of providing online risk information and lifestyle advice for the most common preventable cancers: study protocol.

Usher-Smith JA, Masson G, Mills K, Sharp SJ, Sutton S, Klein WMP, Griffin SJ.

BMC Public Health. 2018 Jun 26;18(1):796. doi: 10.1186/s12889-018-5712-2.

8.

Delivery and impact of the NHS Health Check in the first 8 years: a systematic review.

Martin A, Saunders CL, Harte E, Griffin SJ, MacLure C, Mant J, Meads C, Walter FM, Usher-Smith JA.

Br J Gen Pract. 2018 Jul;68(672):e449-e459. doi: 10.3399/bjgp18X697649. Epub 2018 Jun 18.

PMID:
29914882
9.

How good are GPs at adhering to a pragmatic trial protocol in primary care? Results from the ADDITION-Cambridge cluster-randomised pragmatic trial.

Laxy M, Wilson ECF, Boothby CE, Griffin SJ.

BMJ Open. 2018 Jun 14;8(6):e015295. doi: 10.1136/bmjopen-2016-015295.

10.

The association between psychosocial factors and change in lifestyle behaviour following lifestyle advice and information about cardiovascular disease risk.

Dennison RA, Feldman AL, Usher-Smith JA, Griffin SJ.

BMC Public Health. 2018 Jun 13;18(1):731. doi: 10.1186/s12889-018-5655-7.

11.

Randomised controlled trial of a theory-based behavioural intervention to reduce formula milk intake.

Lakshman R, Sharp SJ, Whittle F, Schiff A, Hardeman W, Irvine L, Wilson E, Griffin SJ, Ong KK.

Arch Dis Child. 2018 Nov;103(11):1054-1060. doi: 10.1136/archdischild-2018-314784. Epub 2018 May 14.

12.

Metformin in non-diabetic hyperglycaemia: the GLINT feasibility RCT.

Griffin SJ, Bethel MA, Holman RR, Khunti K, Wareham N, Brierley G, Davies M, Dymond A, Eichenberger R, Evans P, Gray A, Greaves C, Harrington K, Hitman G, Irving G, Lessels S, Millward A, Petrie JR, Rutter M, Sampson M, Sattar N, Sharp S.

Health Technol Assess. 2018 Apr;22(18):1-64. doi: 10.3310/hta22180.

13.

Dietary cost associated with adherence to the Mediterranean diet, and its variation by socio-economic factors in the UK Fenland Study.

Tong TYN, Imamura F, Monsivais P, Brage S, Griffin SJ, Wareham NJ, Forouhi NG.

Br J Nutr. 2018 Mar;119(6):685-694. doi: 10.1017/S0007114517003993.

14.

Effect of screening for type 2 diabetes on healthcare costs: a register-based study among 139,075 individuals diagnosed with diabetes in Denmark between 2001 and 2009.

Sortsø C, Komkova A, Sandbæk A, Griffin SJ, Emneus M, Lauritzen T, Simmons RK.

Diabetologia. 2018 Jun;61(6):1306-1314. doi: 10.1007/s00125-018-4594-2. Epub 2018 Mar 16.

PMID:
29549417
15.

External validation of risk prediction models for incident colorectal cancer using UK Biobank.

Usher-Smith JA, Harshfield A, Saunders CL, Sharp SJ, Emery J, Walter FM, Muir K, Griffin SJ.

Br J Cancer. 2018 Mar 6;118(5):750-759. doi: 10.1038/bjc.2017.463. Epub 2018 Jan 30.

16.

Effect of interventions incorporating personalised cancer risk information on intentions and behaviour: a systematic review and meta-analysis of randomised controlled trials.

Usher-Smith JA, Silarova B, Sharp SJ, Mills K, Griffin SJ.

BMJ Open. 2018 Jan 23;8(1):e017717. doi: 10.1136/bmjopen-2017-017717. Review.

17.
18.

Lexical neutrality in environmental health research: Reflections on the term walkability.

Hajna S, Ross NA, Griffin SJ, Dasgupta K.

BMC Public Health. 2017 Dec 8;17(1):940. doi: 10.1186/s12889-017-4943-y.

19.

Reasons why people do not attend NHS Health Checks: a systematic review and qualitative synthesis.

Harte E, MacLure C, Martin A, Saunders CL, Meads C, Walter FM, Griffin SJ, Mant J, Usher-Smith JA.

Br J Gen Pract. 2018 Jan;68(666):e28-e35. doi: 10.3399/bjgp17X693929. Epub 2017 Dec 4.

20.

Patients' views on interactions with practitioners for type 2 diabetes: a longitudinal qualitative study in primary care over 10 years.

Dambha-Miller H, Silarova B, Irving G, Kinmonth AL, Griffin SJ.

Br J Gen Pract. 2018 Jan;68(666):e36-e43. doi: 10.3399/bjgp17X693917. Epub 2017 Dec 4.

21.

Views of commissioners, managers and healthcare professionals on the NHS Health Check programme: a systematic review.

Mills K, Harte E, Martin A, MacLure C, Griffin SJ, Mant J, Meads C, Saunders CL, Walter FM, Usher-Smith JA.

BMJ Open. 2017 Nov 15;7(11):e018606. doi: 10.1136/bmjopen-2017-018606. Review.

22.

Interplay of Socioeconomic Status and Supermarket Distance Is Associated with Excess Obesity Risk: A UK Cross-Sectional Study.

Burgoine T, Mackenbach JD, Lakerveld J, Forouhi NG, Griffin SJ, Brage S, Wareham NJ, Monsivais P.

Int J Environ Res Public Health. 2017 Oct 25;14(11). pii: E1290. doi: 10.3390/ijerph14111290.

23.

Factors Associated With Engagement With a Web-Based Lifestyle Intervention Following Provision of Coronary Heart Disease Risk: Mixed Methods Study.

Usher-Smith JA, Winther LR, Shefer GS, Silarova B, Payne RA, Griffin SJ.

J Med Internet Res. 2017 Oct 16;19(10):e351. doi: 10.2196/jmir.7697.

24.

The descriptive epidemiology of the diurnal profile of bouts and breaks in sedentary time in older English adults.

Yerrakalva D, Cooper AJ, Westgate K, Khaw KT, Wareham NJ, Brage S, Griffin SJ, Wijndaele K.

Int J Epidemiol. 2017 Dec 1;46(6):1871-1881. doi: 10.1093/ije/dyx123.

25.

PCSK9 inhibition and type 2 diabetes.

Lotta LA, Griffin SJ.

Lancet Diabetes Endocrinol. 2017 Dec;5(12):926-927. doi: 10.1016/S2213-8587(17)30321-2. Epub 2017 Sep 15. No abstract available.

PMID:
28927707
26.

Effect of screening for type 2 diabetes on risk of cardiovascular disease and mortality: a controlled trial among 139,075 individuals diagnosed with diabetes in Denmark between 2001 and 2009.

Simmons RK, Griffin SJ, Lauritzen T, Sandbæk A.

Diabetologia. 2017 Nov;60(11):2192-2199. doi: 10.1007/s00125-017-4299-y. Epub 2017 Aug 23.

27.

Screening for type 2 diabetes: do screen-detected cases fare better?

Feldman AL, Griffin SJ, Fhärm E, Norberg M, Wennberg P, Weinehall L, Rolandsson O.

Diabetologia. 2017 Nov;60(11):2200-2209. doi: 10.1007/s00125-017-4402-4. Epub 2017 Aug 23.

28.

Effect of population screening for type 2 diabetes and cardiovascular risk factors on mortality rate and cardiovascular events: a controlled trial among 1,912,392 Danish adults.

Simmons RK, Griffin SJ, Witte DR, Borch-Johnsen K, Lauritzen T, Sandbæk A.

Diabetologia. 2017 Nov;60(11):2183-2191. doi: 10.1007/s00125-017-4323-2. Epub 2017 Aug 23.

29.

Mediation and modification of genetic susceptibility to obesity by eating behaviors.

de Lauzon-Guillain B, Clifton EA, Day FR, Clément K, Brage S, Forouhi NG, Griffin SJ, Koudou YA, Pelloux V, Wareham NJ, Charles MA, Heude B, Ong KK.

Am J Clin Nutr. 2017 Oct;106(4):996-1004. doi: 10.3945/ajcn.117.157396. Epub 2017 Aug 16.

30.

Patient experience of NHS health checks: a systematic review and qualitative synthesis.

Usher-Smith JA, Harte E, MacLure C, Martin A, Saunders CL, Meads C, Walter FM, Griffin SJ, Mant J.

BMJ Open. 2017 Aug 11;7(8):e017169. doi: 10.1136/bmjopen-2017-017169. Review.

31.

Sociodemographic, lifestyle and behavioural factors associated with consumption of sweetened beverages among adults in Cambridgeshire, UK: the Fenland Study.

Barrett P, Imamura F, Brage S, Griffin SJ, Wareham NJ, Forouhi NG.

Public Health Nutr. 2017 Oct;20(15):2766-2777. doi: 10.1017/S136898001700177X. Epub 2017 Aug 9.

32.

Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with type 2 diabetes.

Griffin SJ, Leaver JK, Irving GJ.

Diabetologia. 2017 Sep;60(9):1620-1629. doi: 10.1007/s00125-017-4337-9. Epub 2017 Aug 2. Review.

33.

Risk accuracy of type 2 diabetes in middle aged adults: Associations with sociodemographic, clinical, psychological and behavioural factors.

Silarova B, Douglas FE, Usher-Smith JA, Godino JG, Griffin SJ.

Patient Educ Couns. 2018 Jan;101(1):43-51. doi: 10.1016/j.pec.2017.07.023. Epub 2017 Jul 21.

34.

Intakes and sources of dietary sugars and their association with metabolic and inflammatory markers.

O'Connor L, Imamura F, Brage S, Griffin SJ, Wareham NJ, Forouhi NG.

Clin Nutr. 2018 Aug;37(4):1313-1322. doi: 10.1016/j.clnu.2017.05.030. Epub 2017 Jun 17.

35.

Change in lifestyle behaviors and diabetes risk: evidence from a population-based cohort study with 10 year follow-up.

Feldman AL, Long GH, Johansson I, Weinehall L, Fhärm E, Wennberg P, Norberg M, Griffin SJ, Rolandsson O.

Int J Behav Nutr Phys Act. 2017 Mar 29;14(1):39. doi: 10.1186/s12966-017-0489-8.

36.

Accessibility and Affordability of Supermarkets: Associations With the DASH Diet.

Mackenbach JD, Burgoine T, Lakerveld J, Forouhi NG, Griffin SJ, Wareham NJ, Monsivais P.

Am J Prev Med. 2017 Jul;53(1):55-62. doi: 10.1016/j.amepre.2017.01.044. Epub 2017 Mar 20.

37.
38.

Impact of weight maintenance and loss on diabetes risk and burden: a population-based study in 33,184 participants.

Feldman AL, Griffin SJ, Ahern AL, Long GH, Weinehall L, Fhärm E, Norberg M, Wennberg P.

BMC Public Health. 2017 Feb 6;17(1):170. doi: 10.1186/s12889-017-4081-6.

39.

Does Training and Support of General Practitioners in Intensive Treatment of People with Screen-Detected Diabetes Improve Medication, Morbidity and Mortality in People with Clinically-Diagnosed Diabetes? Investigation of a Spill-Over Effect in a Cluster RCT.

Charles M, Skriver MV, Griffin SJ, Simmons RK, Witte DR, Dalsgaard EM, Lauritzen T, Sandbæk A.

PLoS One. 2017 Feb 2;12(2):e0170697. doi: 10.1371/journal.pone.0170697. eCollection 2017.

40.

Associations between body mass index-related genetic variants and adult body composition: The Fenland cohort study.

Clifton EA, Day FR, De Lucia Rolfe E, Forouhi NG, Brage S, Griffin SJ, Wareham NJ, Ong KK.

Int J Obes (Lond). 2017 Apr;41(4):613-619. doi: 10.1038/ijo.2017.11. Epub 2017 Jan 18.

41.

Statins for primary prevention in people with a 10% 10-year cardiovascular risk: too much medicine too soon?

Yerrakalva D, Griffin SJ.

Br J Gen Pract. 2017 Jan;67(654):40-41. doi: 10.3399/bjgp17X688789. No abstract available.

42.

Cardiovascular risk factors and incident albuminuria in screen-detected type 2 diabetes.

Webb DR, Zaccardi F, Davies MJ, Griffin SJ, Wareham NJ, Simmons RK, Rutten GE, Sandbaek A, Lauritzen T, Borch-Johnsen K, Khunti K.

Diabetes Metab Res Rev. 2017 May;33(4). doi: 10.1002/dmrr.2877. Epub 2017 Mar 2.

43.

Impact of sit-stand desks at work on energy expenditure and sedentary time: protocol for a feasibility study.

Mantzari E, Wijndaele K, Brage S, Griffin SJ, Marteau TM.

Pilot Feasibility Stud. 2016 Jul 18;2:30. eCollection 2016.

44.

Lifestyle Advice Combined with Personalized Estimates of Genetic or Phenotypic Risk of Type 2 Diabetes, and Objectively Measured Physical Activity: A Randomized Controlled Trial.

Godino JG, van Sluijs EM, Marteau TM, Sutton S, Sharp SJ, Griffin SJ.

PLoS Med. 2016 Nov 29;13(11):e1002185. doi: 10.1371/journal.pmed.1002185. eCollection 2016 Nov.

45.

Fruit and vegetable intake and cardiovascular risk factors in people with newly diagnosed type 2 diabetes.

Lamb MJ, Griffin SJ, Sharp SJ, Cooper AJ.

Eur J Clin Nutr. 2017 Jan;71(1):115-121. doi: 10.1038/ejcn.2016.180. Epub 2016 Oct 19.

46.

A randomised trial of the effect and cost-effectiveness of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with screen-detected type 2 diabetes: the Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care (ADDITION-Europe) study.

Simmons RK, Borch-Johnsen K, Lauritzen T, Rutten GE, Sandbæk A, van den Donk M, Black JA, Tao L, Wilson EC, Davies MJ, Khunti K, Sharp SJ, Wareham NJ, Griffin SJ.

Health Technol Assess. 2016 Aug;20(64):1-86. doi: 10.3310/hta20640.

47.

Response to commentary to 'Testicular atrophy following paediatric primary orchidopexy: A prospective study'.

Griffin SJ.

J Pediatr Urol. 2016 Oct;12(5):315. doi: 10.1016/j.jpurol.2016.06.009. Epub 2016 Jul 21. No abstract available.

PMID:
27524423
48.

Testicular atrophy following paediatric primary orchidopexy: A prospective study.

Durell J, Johal N, Burge D, Wheeler R, Griffiths M, Kitteringham L, Stanton M, Manoharan S, Steinbrecher H, Malone P, Griffin SJ.

J Pediatr Urol. 2016 Aug;12(4):243.e1-4. doi: 10.1016/j.jpurol.2016.05.023. Epub 2016 Jun 13.

PMID:
27422375
49.

The spectrum effect in tests for risk prediction, screening, and diagnosis.

Usher-Smith JA, Sharp SJ, Griffin SJ.

BMJ. 2016 Jun 22;353:i3139. doi: 10.1136/bmj.i3139. No abstract available.

50.

Risk prediction models for colorectal cancer in people with symptoms: a systematic review.

Williams TG, Cubiella J, Griffin SJ, Walter FM, Usher-Smith JA.

BMC Gastroenterol. 2016 Jun 13;16(1):63. doi: 10.1186/s12876-016-0475-7. Review.

Supplemental Content

Loading ...
Support Center